Microbiological links between periodontitis and systemic diseases: a brief review

키워드

참고문헌 (133)

1. Williams RC, "Periodontal medicine : the emergence of a new branch of periodontology", Periodontol 2000, 23, pp.9~12 (2000)[DOI]
2. Chapple IL, "Diabetes and periodontal diseases: consensus report of the joint EFP", AAP workshop on periodontitis and systemic diseases, 2013, pp.84(4 Suppl), S106~S112
3. Sanz M, "Periodontitis and cardiovascular diseases Consensus report", Glob Heart, 15, pp.1~ (2020)[DOI]
4. Nwizu N, "Periodontal disease and cancer : epidemiologic studies and possible mechanisms", Periodontol 2000, 83, pp.213~233 (2020)[DOI]
5. Hajishengallis G, "Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities", Nat Rev Immunol, 21, pp.426~440 (2021)[DOI]
6. Kinane DF, "Bacteraemia following periodontal procedures", J Clin Periodontol, 32, pp.708~713 (2005)[DOI]
7. Scannapieco FA, "Systemic effects of periodontal diseases", Dent Clin North Am, 49, pp.533~550 (2005)[DOI]
8. Lockhart PB, "Bacteremia associated with toothbrushing and dental extraction", Circulation, 117, pp.3118~3125 (2008)[DOI]
9. Castillo DM, "Detection of specific periodontal microorganisms from bacteraemia samples after periodontal therapy using molecular-based diagnostics", J Clin Periodontol, 38, pp.418~427 (2011)[DOI]
10. Dentino A, "Principles of periodontology", Periodontol 2000, 61, pp.16~53 (2013)[DOI]
11. Darveau RP, "Periodontitis : a polymicrobial disruption of host homeostasis", Nat Rev Microbiol, 8, pp.481~490 (2010)[DOI]
12. Hajishengallis G, "Beyond the red complex and into more complexity : the polymicrobial synergy and dysbiosis(PSD)model of periodontal disease etiology", Mol Oral Microbiol, 27, pp.409~419 (2012)[DOI]
13. Sanz M, "Periodontitis and cardiovascular diseases : consensus report", J Clin Periodontol, 47, pp.268~288 (2020)[DOI]
14. Friedewald VE, "The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease", Am J Cardiol, 104, pp.59~68 (2009)[DOI]
15. Kebschull M, "”Gum bug, leave my heart alone!”--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis", J Dent Res, 89, pp.879~902 (2010)[DOI]
16. Desvarieux M, "Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness : the Oral Infections and Vascular Disease Epidemiology study", J Am Heart Assoc, 2, pp.e000254~ (2013)[DOI]
17. Yuan H, "Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss", Proc Natl Acad Sci U S A, 110, pp.E5059~E5068 (2013)[DOI]
18. Liljestrand JM, "Immunologic burden links periodontitis to acute coronary syndrome", Atherosclerosis, 268, pp.177~184 (2018)[DOI]
19. Schenkein HA, "Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor", Infect Immun, 68, pp.5416~5419 (2000)[DOI]
20. Rivera MF, "Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null)mice", PLoS One, 8, pp.e57178~ (2013)[DOI]
21. Kozarov EV, "Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis", Arterioscler Thromb Vasc Biol, 25, pp.e17~e18 (2005)[DOI]
22. Schenkein HA, "Mechanisms underlying the association between periodontitis and atherosclerotic disease", Periodontol 2000, 83, pp.90~106 (2020)[DOI]
23. Zhu J, "Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels", Am J Cardiol, 85, pp.140~146 (2000)[DOI]
24. Genco RJ, "Prevention : reducing the risk of CVD in patients with periodontitis", Nat Rev Cardiol, 7, pp.479~480 (2010)[DOI]
25. Offenbacher S, "Results from the Periodontitis and Vascular Events(PAVE)Study : a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease", J Periodontol, 80, pp.190~201 (2009)[DOI]
26. Yu KM, "The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model", Thromb Res, 127, pp.418~425 (2011)[DOI]
27. Haraszthy VI, "Identification of periodontal pathogens in atheromatous plaques", J Periodontol, 71, pp.1554~1560 (2000)[DOI]
28. Reyes L, "Periodontal bacterial invasion and infection : contribution to atherosclerotic pathology", J Clin Periodontol, 40(Suppl 14), pp.S30~S50 (2013)[DOI]
29. Brodala N, "Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs", Arterioscler Thromb Vasc Biol, 25, pp.1446~1451 (2005)[DOI]
30. Delbosc S, "Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation Proof of concept in rats", PLoS One, 6, pp.e18679~ (2011)[DOI]
31. Nakayama K, "Porphyromonas gingivalis cell-induced hemagglutination and platelet aggregation", Periodontol 2000, 54, pp.45~52 (2010)[DOI]
32. Arimatsu K, "Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota", Sci Rep, 4, pp.4828~ (2014)[DOI]
33. Sanz M, "Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology", J Clin Periodontol, 45, pp.138~149 (2018)[DOI]
34. Rylander H, "Prevalence of periodontal disease in young diabetics", J Clin Periodontol, 14, pp.38~43 (1987)[DOI]
35. Cianciola LJ, "Prevalence of periodontal disease in insulin-dependent diabetes mellitus(juvenile diabetes)", J Am Dent Assoc, 104, pp.653~660 (1982)[DOI]
36. Thorstensson H, "Periodontal disease experience in adult long-duration insulin-dependent diabetics", J Clin Periodontol, 20, pp.352~358 (1993)[DOI]
37. Emrich LJ, "Periodontal disease in non-insulin-dependent diabetes mellitus", J Periodontol, 62, pp.123~131 (1991)[DOI]
38. Westfelt E, "The effect of periodontal therapy in diabetics Results after 5 years", J Clin Periodontol, 23, pp.92~100 (1996)[DOI]
39. D'Aiuto F, "Systemic effects of periodontitis treatment in patients with type 2 diabetes : a 12month, single-centre, investigator-masked, randomised trial", Lancet Diabetes Endocrinol, 6, pp.954~965 (2018)[DOI]
40. Zenobia C, "Does oral endotoxin contribute to systemic inflammation?", Front Oral Health, 3, pp.911420~ (2022)[DOI]
41. Graziani F, "A systematic review and meta-analysis of epidemiologic observational evidence on the effect of periodontitis on diabetes An update of the EFP-AAP review", J Clin Periodontol, 45, pp.167~187 (2018)[DOI]
42. Casarin RC, "Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis", J Periodontal Res, 48, pp.30~36 (2013)[DOI]
43. Xiao E, "Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity", Cell Host Microbe, 22, pp.120~128 (2017)[DOI]
44. Hajishengallis G, "Periodontitis : from microbial immune subversion to systemic inflammation", Nat Rev Immunol, 15, pp.30~44 (2015)[DOI]
45. Komazaki R, "Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism", Sci Rep, 7, pp.13950~ (2017)[DOI]
46. Ohtsu A, "Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice", Oral Dis, 25, pp.868~880 (2019)[DOI]
47. Kashiwagi Y, "Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model", Sci Rep, 11, pp.18398~ (2021)[DOI]
48. Sanz M, "Periodontitis and adverse pregnancy outcomes: consensus report of the joint EFP", AAP workshop on periodontitis and systemic diseases, 2013, pp.84(4 Suppl), S164~S169
49. Madianos PN, "Adverse pregnancy outcomes(APOs)and periodontal disease : pathogenic mechanisms", J Periodontol, 84(4 Suppl), pp.S170~S180 (2013)[DOI]
50. Han YW, "Oral health and adverse pregnancy outcomes – what’s next?", J Dent Res, 90, pp.289~293 (2011)[DOI]
51. Han YW, "Term stillbirth caused by oral Fusobacterium nucleatum", Obstet Gynecol, 115(2), pp.442~445 (2010)[DOI]
52. Gonzales-Marin C, "Maternal oral origin of Fusobacterium nucleatum in adverse pregnancy outcomes as determined using the 16S-23S rRNA gene intergenic transcribed spacer region", J Med Microbiol, 62(Pt 1), pp.133~144 (2013)[DOI]
53. Collins JG, "Effects of Escherichia coli and Porphyromonas gingivalis lipopolysaccharide on pregnancy outcome in the golden hamster", Infect Immun, 62, pp.4652~4655 (1994)[DOI]
54. Collins JG, "Effects of a Porphyromonas gingivalis infection on inflammatory mediator response and pregnancy outcome in hamsters", Infect Immun, 62, pp.4356~4361 (1994)[DOI]
55. Han YW, "Identification and characterization of a novel adhesin unique to oral fusobacteria", J Bacteriol, 187, pp.5330~5340 (2005)[DOI]
56. Han YW, "Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice : implication of oral bacteria in preterm birth", Infect Immun, 72, pp.2272~2279 (2004)[DOI]
57. Ikegami A, "Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization", Infect Immun, 77, pp.3075~3079 (2009)[DOI]
58. Fardini Y, "Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity", Mol Microbiol, 82, pp.1468~1480 (2011)[DOI]
59. Han YW, "Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer", Adv Dent Res, 26, pp.47~55 (2014)[DOI]
60. Schenkein HA, "Anticardiolipin in porphyromonas gingivalis antisera causes fetal loss in mice", J Dent Res, 92, pp.814~818 (2013)[DOI]
61. Aletaha D, "Diagnosis and management of rheumatoid arthritis : a review", JAMA, 320, pp.1360~1372 (2018)[DOI]
62. Okada Y, "Genetics of rheumatoid arthritis contributes to biology and drug discovery", Nature, 506, pp.376~381 (2014)[DOI]
63. Dissick A, "Association of periodontitis with rheumatoid arthritis : a pilot study", J Periodontol, 81, pp.223~230 (2010)[DOI]
64. Koziel J, "Pros and cons of causative association between periodontitis and rheumatoid arthritis", Periodontol 2000, 89, pp.83~98 (2022)[DOI]
65. Zhang X, "The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment", Nat Med, 21, pp.895~905 (2015)[DOI]
66. Scherer HU, "The etiology of rheumatoid arthritis", J Autoimmun, 110, pp.102400~ (2020)[DOI]
67. Kolarz B, "The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA", RF negative rheumatoid arthritis patients, 2021, pp.13, ~
68. de Molon RS, "Linkage of periodontitis and rheumatoid arthritis : current evidence and potential biological interactions", Int J Mol Sci, 20, pp.4541~ (2019)[DOI]
69. Krutyhołowa A, "Host and bacterial factors linking periodontitis and rheumatoid arthritis", Front Immunol, 13, pp.980805~ (2022)[DOI]
70. Li Y, "The relationship between Porphyromonas gingivalis and Rheumatoid arthritis : a meta-analysis", Front Cell Infect Microbiol, 12, pp.956417~ (2022)[DOI]
71. Maresz KJ, "Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase(PAD)", PLoS Pathog, 9, pp.e1003627~ (2013)[DOI]
72. Gully N, "Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis", PLoS One, 9, pp.e100838~ (2014)[DOI]
73. Sato K, "Aggravation of collageninduced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system", Sci Rep, 7, pp.6955~ (2017)[DOI]
74. Wegner N, "Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase : implications for autoimmunity in rheumatoid arthritis", Arthritis Rheum, 62, pp.2662~2672 (2010)[DOI]
75. Courbon G, "Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat", Ann Rheum Dis, 78, pp.594~599 (2019)[DOI]
76. Konig MF, "Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis", Sci Transl Med, 8, pp.369~ (2016)[DOI]
77. Scannapieco FA, "Oral inflammation and infection, and chronic medical diseases : implications for the elderly", Periodontol 2000, 72, pp.153~175 (2016)[DOI]
78. Aoki K, "Detection of associated bacteria in aspiration pneumonia and lung abscesses using partial 16S rRNA gene amplicon sequencing", Anaerobe, 69, pp.102325~ (2021)[DOI]
79. Pathak JL, "The role of oral microbiome in respiratory health and diseases", Respir Med, 185, pp.106475~ (2021)[DOI]
80. Kimizuka R, "Mixed infections with Porphyromonas gingivalis and Treponema denticola cause excessive inflammatory responses in a mouse pneumonia model compared with monoinfections", Microbes Infect, 5, pp.1357~1362 (2003)[DOI]
81. Khadka S, "Poor oral hygiene, oral microorganisms and aspiration pneumonia risk in older people in residential aged care : a systematic review", Age Ageing, 50, pp.81~87 (2021)[DOI]
82. Scannapieco FA, "Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease A systematic review", Ann Periodontol, 8, pp.54~69 (2003)[DOI]
83. Gomes-Filho IS, "Periodontitis and respiratory diseases : a systematic review with meta-analysis", Oral Dis, 26, pp.439~446 (2020)[DOI]
84. Lee E, "Prevalence of periodontitis and its association with reduced pulmonary function : results from the Korean National Health and Nutrition Examination Survey", Medicina(Kaunas), 55, pp.581~ (2019)[DOI]
85. Sethi S, "Infection in the pathogenesis and course of chronic obstructive pulmonary disease", N Engl J Med, 359, pp.2355~2365 (2008)[DOI]
86. Tan L, "16S rDNA-based metagenomic analysis of dental plaque and lung bacteria in patients with severe acute exacerbations of chronic obstructive pulmonary disease", J Periodontal Res, 49, pp.760~769 (2014)[DOI]
87. Pan Y, "Oral bacteria modulate invasion and induction of apoptosis in HEp-2 cells by Pseudomonas aeruginosa", Microb Pathog, 46, pp.73~79 (2009)[DOI]
88. Li Q, "Porphyromonas gingivalis modulates Pseudomonas aeruginosa-induced apoptosis of respiratory epithelial cells through the STAT3 signaling pathway", Microbes Infect, 16, pp.17~27 (2014)[DOI]
89. Kavarthapu A, "Linking chronic periodontitis and oral cancer : a review", Oral Oncol, 121, pp.105375~ (2021)[DOI]
90. Komlós G, "Periodontitis as a risk for oral cancer : a case-control study", BMC Oral Health, 21, pp.640~ (2021)[DOI]
91. Söder B, "Periodontal disease may associate with breast cancer", Breast Cancer Res Treat, 127, pp.497~502 (2011)[DOI]
92. Coussens LM, "Inflammation and cancer", Nature, 420, pp.860~867 (2002)[DOI]
93. Hanahan D, "Hallmarks of cancer : the next generation", Cell, 144, pp.646~674 (2011)[DOI]
94. Algra AM, "Effects of regular aspirin on long-term cancer incidence and metastasis : a systematic comparison of evidence from observational studies versus randomised trials", Lancet Oncol, 13, pp.518~527 (2012)[DOI]
95. Flossmann E, "Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies", Lancet, 369, pp.1603~1613 (2007)[DOI]
96. Nguyen LH, "Pathways of colorectal carcinogenesis", Gastroenterology, 158, pp.291~302 (2020)[DOI]
97. Siemes C, "Creactive protein levels, variation in the C-reactive protein gene, and cancer risk : the Rotterdam Study", J Clin Oncol, 24, pp.5216~5222 (2006)[DOI]
98. Trichopoulos D, "Plasma C-reactive protein and risk of cancer : a prospective study from Greece", Cancer Epidemiol Biomarkers Prev, 15, pp.381~384 (2006)[DOI]
99. Meurman JH, "Oral microbiota and cancer", J Oral Microbiol, 2, pp.5195~5204 (2010)[DOI]
100. Olsen I, "Possible role of Porphyromonas gingivalis in orodigestive cancers", J Oral Microbiol, 11, pp.1563410~ (2019)[DOI]
101. Tan Q, "Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils", Gut Microbes, 14, pp.2073785~ (2022)[DOI]
102. Fan X, "Human oral microbiome and prospective risk for pancreatic cancer : a population-based nested case-control study", Gut, 67, pp.120~127 (2018)[DOI]
103. Inaba H, "Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation", Cell Microbiol, 16, pp.131~145 (2014)[DOI]
104. Kuboniwa M, "Gingivalis accelerates gingival epithelial cell progression through the cell cycle", Microbes Infect, 10, pp.122~128 (2008)[DOI]
105. Meurman JH, "Infectious and dietary risk factors of oral cancer", Oral Oncol, 46, pp.411~413 (2010)[DOI]
106. Ahn J, "Oral microbiome and oral and gastrointestinal cancer risk", Cancer Causes Control, 23, pp.399~404 (2012)[DOI]
107. Peters BA, "The oral microbiome and prospective risk for esophageal cancer : a population-based nested case-control study", Cancer Res, 77(Suppl 13), pp.4961~ (2017)[DOI]
108. Mima K, "Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis", Gut, 65, pp.1973~1980 (2016)[DOI]
109. Wang S, "Fusobacterium nucleatum acts as a pro-carcinogenic bacterium in colorectal cancer : from association to causality", Front Cell Dev Biol, 9, pp.710165~ (2021)[DOI]
110. Rubinstein MR, "Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin", β-catenin signaling via its FadA adhesin, 2013, pp.14, 195~206
111. Kostic AD, "Genomic analysis identifies association of Fusobacterium with colorectal carcinoma", Genome Res, 22, pp.292~298 (2012)[DOI]
112. Bashir A, "Fusobacterium nucleatum, inflammation, and immunity : the fire within human gut", Tumour Biol, 37, pp.2805~2810 (2016)[DOI]
113. Binder Gallimidi A, "Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model", Oncotarget, 6, pp.22613~22623 (2015)[DOI]
114. Rutsch A, "The gut-brain axis : how microbiota and host inflammasome influence brain physiology and pathology", Front Immunol, 11, pp.604179~ (2020)[DOI]
115. Dantzer R, "Neuroimmune mechanisms of comorbid chronic pain and depression", Biol Psychiatry, 81, pp.S14~S15 (2017)[DOI]
116. Capuron L, "Immune system to brain signaling : neuropsychopharmacological implications", Pharmacol Ther, 130, pp.226~238 (2011)[DOI]
117. Rudzki L, "The Microbiota-Gut-Immune-Glia(MGIG)axis in major depression", Mol Neurobiol, 57, pp.4269~4295 (2020)[DOI]
118. Wu Q, "The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice", J Neurosci Res, 95, pp.2483~2492 (2017)[DOI]
119. Holmes C, "Review : systemic inflammation and Alzheimer’s disease", Neuropathol Appl Neurobiol, 39, pp.51~68 (2013)[DOI]
120. Wu Z, "Connection between periodontitis and Alzheimer’s disease : possible roles of microglia and leptomeningeal cells", J Pharmacol Sci, 126, pp.8~13 (2014)[DOI]
121. Kamer AR, "Periodontal disease as a possible cause for Alzheimer’s disease", Periodontol 2000, 83, pp.242~271 (2020)[DOI]
122. Kouki MA, "Do periodontal pathogens or associated virulence factors have a deleterious effect on the blood-brain barrier, contributing to Alzheimer’s disease?", J Alzheimers Dis, 85, pp.957~973 (2022)[DOI]
123. Dioguardi M, "The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer’s disease : a systematic review", J Clin Med, 9, pp.495~ (2020)[DOI]
124. Kamer AR, "TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer’s disease patients and normal subjects", J Neuroimmunol, 216, pp.92~97 (2009)[DOI]
125. Sparks Stein P, "Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease", Alzheimers Dement, 8, pp.196~203 (2012)[DOI]
126. Jungbauer G, "Periodontal microorganisms and Alzheimer disease-a causative relationship?", Periodontol 2000, 89, pp.59~82 (2022)[DOI]
127. Dominy SS, "Porphyromonas gingivalis in Alzheimer’s disease brains : evidence for disease causation and treatment with small-molecule inhibitors", Sci Adv, 5, pp.eaau3333~ (2019)[DOI]
128. Ide M, "Periodontitis and cognitive decline in Alzheimer’s disease", PLoS One, 11, pp.e0151081~ (2016)[DOI]
129. Ishida N, "Periodontitis induced by bacterial infection exacerbates features of Alzheimer’s disease in transgenic mice", NPJ Aging Mech Dis, 3, pp.15~ (2017)[DOI]
130. Ilievski V, "Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice", PLoS One, 13, pp.e0204941~ (2018)[DOI]
131. Kanagasingam S, "Porphyromonas gingivalis is a strong risk factor for Alzheimer’s disease", J Alzheimers Dis Rep, 4, pp.501~511 (2020)[DOI]
132. Haditsch U, "Alzheimer’s diseaselike neurodegeneration in Porphyromonas gingivalis infected neurons with persistent expression of active gingipains", J Alzheimers Dis, 75, pp.1361~1376 (2020)[DOI]
133. Kanagasingam S, "Antimicrobial, polarizing light, and paired helical filament properties of fragmented tau peptides of selected putative gingipains", J Alzheimers Dis, 89, pp.1279~1291 (2022)[DOI]

관련 논문AI추천